Document Detail


Incidence of late lepra reaction among multibacillary leprosy patients after MDT.
MedLine Citation:
PMID:  7730714     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Multidrug therapy (MDT) recommended by the World Health Organization (WHO) had been administered in 1982 to a cohort of multibacillary (MB) leprosy patients. Treatment was administered for a minimum period of 2 years or until skin-smear negativity for acid-fast bacilli was achieved (whichever was later). Among 980 MB leprosy patients who completed treatment, 11 patients (1.1%) experienced lepra reactions during surveillance. Probable predictive factors are discussed. The incidence of lepra reaction seemed to be three times more common in borderline (BL) leprosy than in lepromatous (LL) leprosy. The majority of these events occurred during the first 3 years of surveillance. All of these episodes were treated with steroids without antileprosy chemotherapy. None of these patients was confirmed as experiencing a relapse during the subsequent period of surveillance.
Authors:
P Vijayakumaran; N Manimozhi; K Jesudasan
Related Documents :
22356304 - Formalin dab, the effective way of treating haemorrhagic radiation proctitis: a randomi...
11930834 - Clinico-electrophysiological correlates in patients with relapsing-remitting multiple s...
22504994 - Neuromuscular adaptations in gluteus medius activity following resurfacing and total hi...
22605014 - Cost-effectiveness of 2 approaches to managing nasolacrimal duct obstruction in infants...
20055724 - Varicella-zoster virus pneumonia in an adult population: has mortality decreased?
7002354 - The persantine-aspirin reinfarction study. the persantine-aspirin reinfarction study (p...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association     Volume:  63     ISSN:  0148-916X     ISO Abbreviation:  Int. J. Lepr. Other Mycobact. Dis.     Publication Date:  1995 Mar 
Date Detail:
Created Date:  1995-05-30     Completed Date:  1995-05-30     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  8505819     Medline TA:  Int J Lepr Other Mycobact Dis     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  18-22     Citation Subset:  IM    
Affiliation:
Branch of Epidemiology and Leprosy Control, Schieffelin Leprosy Research and Training Center, Karigiri, India.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Colony Count, Microbial
Drug Therapy, Combination
Humans
Incidence
Leprostatic Agents / therapeutic use*
Leprosy, Borderline / complications,  drug therapy*,  microbiology
Leprosy, Lepromatous / complications,  drug therapy*,  microbiology
Mycobacterium leprae / growth & development
Recurrence
Chemical
Reg. No./Substance:
0/Leprostatic Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Are 18 doses of WHO/MDT sufficient for multibacillary leprosy; results of a trial in Malawi.
Next Document:  Doppler sonography of vertebral arteries and audiovestibular system investigation in leprosy.